Robeco Institutional Asset Management B.V. Vanda Pharmaceuticals Inc. Transaction History

Robeco Institutional Asset Management B.V.

$51.9 Billion
Q4 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$3.38 - $4.58 $71,963 - $97,512	21,291 Added 110.57%	40,547 $171,000
Q4 2023 Feb 08, 2024	SELL	$3.38 - $4.58 $102,393 - $138,746	-30,294 Reduced 61.14%	19,256 $40.5 Million
Q4 2022 Feb 06, 2023	BUY	$6.87 - $10.96 $132,288 - $211,045	19,256 Added 63.56%	49,550 $366,000
Q3 2022 Dec 01, 2022	BUY	$9.44 - $11.76 $228,872 - $285,121	24,245 Added 400.81%	30,294 $300,000
Q3 2022 Oct 26, 2022	BUY	$9.44 - $11.76 $228,872 - $285,121	24,245 Added 400.81%	30,294 $300,000
Q4 2021 Dec 01, 2022	SELL	$15.69 - $21.14 $311,540 - $419,755	-19,856 Reduced 76.65%	6,049 $95,000
Q4 2021 Jan 31, 2022	SELL	$15.69 - $21.14 $311,540 - $419,755	-19,856 Reduced 76.65%	6,049 $95,000
Q3 2021 Dec 01, 2022	SELL	$15.35 - $21.27 $67,371 - $93,354	-4,389 Reduced 14.49%	25,905 $444,000
Q3 2021 Oct 20, 2021	BUY	$15.35 - $21.27 $397,641 - $550,999	25,905 New	25,905 $444,000

Others Institutions Holding VNDA

# of Institutions

154

Shares Held

43.8M

Call Options Held

33.8K

Put Options Held

28.7K

Black Rock Inc. New York, NY

8.14M
Shares

$36 Million
0.0% of portfolio
Jim Simons Renaissance Technologies LLC | New York, Ny

3.85M
Shares

$17 Million
0.03% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$15.5 Million
0.0% of portfolio
Dimensional Fund Advisors LP Austin, TX

2.49M
Shares

$11 Million
0.0% of portfolio
Tang Capital Management LLC San Diego, CA

2.35M
Shares

$10.4 Million
0.85% of portfolio

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $250M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Account